TrialRadiology and oncology2023

Effectiveness and safety of anlotinib with or without S-1 in the treatment of patients with advanced hepatocellular carcinoma in a Chinese population: a prospective, phase 2 study.

Mafei Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.